Immunology
-
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
This article has 9 authors:Reviewed by ScreenIT
-
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine
This article has 20 authors:Reviewed by ScreenIT
-
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
This article has 31 authors:Reviewed by ScreenIT
-
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis
This article has 10 authors:Reviewed by ScreenIT
-
Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow immunoassay device compared with a nucleocapsid-only device
This article has 4 authors:Reviewed by ScreenIT
-
SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses
This article has 5 authors:Reviewed by ScreenIT
-
A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
This article has 10 authors:Reviewed by ScreenIT
-
Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
This article has 14 authors:Reviewed by ScreenIT
-
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
This article has 38 authors:Reviewed by ScreenIT